A study published in The Lancet HIV today showed that while the rate of newly reported HIV cases in Europe remained steady in younger people between 2004 and 2015, it increased by 2% each year overall in older people. With around 30 000 newly diagnosed ...

Janssen-Cilag International NV (Janssen) today announced that the European Commission has approved the use of Symtuza® (darunavir/cobicistat/emtricitabine/tenofovir alafenamide [D/C/F/TAF]), a once-daily darunavir-based single-tablet regimen (STR), for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years and older with ...

A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys. Plans are under way to try the so-called trispecific antibody in initial human trials before the end of 2018, ...

To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. Methods: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who initiated raltegravir or dolutegravir between 2006 and 2015 were investigated concerning treatment modification within the first ...

On September 25-26,the Regional Office for Europe of the World Health Organization convenes in Copenhagen a meeting of leaders of national HIV programs from Eastern Europe, Central Asia and non-EU/EEA countries. The purpose of this meeting is to support participating countries in the preparation or updating ...

A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries (LMICs) at around US$75 per person, per year. The agreement is expected to ...

On September 25, the third expert meeting "HIV Outcomes: Beyond Viral Suppression" is held in Brussels, where political priorities on HIV are discussed: long-term health, concomitant diseases and the sustainability of the public health care service. Policymakers and stakeholders from HIV communities and health policy ...

The National Consortium of Armenian Communities, which includes three organizations: "Real World, Real People", "Pink Armenia" and "Awakening Potential", initiated the creation of the Platform for Communication and Cooperation of organizations and activists working in the field of the  response to HIV / AIDS and ...

The Bill and Melinda Gates Foundation is to invest up to $40 million in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases. Oxford-based Immunocore has so far concentrated on developing its T-cell receptor medicines to fight cancer, where it ...

One of the most vulnerable populations that is often overlooked when it comes to treating and preventing HIV is older adults. Prior research has demonstrated that stigma due to age is common among older Americans living with HIV, which can often intensify transmission of the virus. According to ...

The Institute for Health Metrics and Evaluation (IHME) at the University of Washington is releasing new findings related to the Sustainable Development Goals in a scientific paper, a data visualization tool, and a report produced in collaboration with the Bill & Melinda Gates Foundation. The publishing of ...

The aim of the study was to assess, among people living with HIV, knowledge of their latest HIV viral load (VL) and CD4 count. Methods Agreement between self-report and clinic record was assessed among 2771 HIV-diagnosed individuals on antiretroviral treatment (ART) in the UK Antiretrovirals, Sexual Transmission ...

In early September, Poland became the platform for the first presentation and discussion of the "Concept of the East Europe and Central Asia Union of People Living with HIV on access to treatment in the EECA region". The key aspect of the Concept is the ...

On September 6, in Poland, the ECUO held a working meeting jointly with the international experts, representatives of governmental institutions and activists of PLHIV communities, to discuss the new concept of access to innovative treatment. You can review the concept here. Without exaggeration, it is a landmark meeting that took place on the edge of two Europes: East and West. In West Europe, the epidemic is brought under control already, so HIV-infected people have an opportunity ...

4 September 2017 Dear Colleagues, With this letter, the members of the Steering Committee (SC) of the Eurasian Harm Reduction Network (EHRN) and staff of the secretariat want to share information about their resignation from EHRN effective as of 4 September 2017.  This resignation comes in response ...

HIV-positive U.S. residents in the large NA-ACCORD cohort had an atherosclerotic myocardial infarction (MI) rate 20% higher than people in a U.S. general-population cohort, newly published data reveal. This 29,169-person analysis also linked MI risk to lower CD4 count, higher viral load and a host ...